MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
MANNKIND CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.09+0.05 (+1.64%)
Close on Oct 19, 2026
- Market cap
- $955.40M
- P/E (TTM)
- –
- Dividend yield
- –
Mannkind statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Mannkind | Industry median |
|---|---|---|
| Market Cap | $993.56M | $164.85M |
| Enterprise Value | $882.43M | $87.06M |
| PS Ratio | 2.52 | 3.60 |
Enterprise value
| Measure | Mannkind | Industry median |
|---|---|---|
| EV / Sales | 2.24 | 2.43 |
| EV / EBITDA | 29.35 | 14.69 |
| EV / EBIT | 96.00 | 18.47 |
Income (trailing twelve months)
| Measure | Mannkind | Industry median |
|---|---|---|
| Revenue | $393.63M | $57.94M |
| Gross Profit | $353.29M | $90.47M |
| Operating Income | $9.19M | -$21.44M |
| Pretax Income | -$48.65M | -$14.45M |
| Net Income | -$43.61M | -$22.46M |
| EBITDA | $30.06M | -$16.91M |
| EPS (Diluted) | -$0.13 | -$0.83 |
Margins
| Measure | Mannkind | Industry median |
|---|---|---|
| Gross Margin | 89.8% | 52.3% |
| Operating Margin | 2.34% | -44.5% |
| Pretax Margin | -12.4% | -13.0% |
| Profit Margin | -11.1% | -39.2% |
| EBITDA Margin | 7.64% | -31.3% |
| FCF Margin | -4.61% | -8.85% |
Returns
| Measure | Mannkind | Industry median |
|---|---|---|
| Return on Assets (ROA) | -7.62% | -41.0% |
| Return on Capital Employed (ROCE) | 1.56% | -37.8% |
Growth
| Measure | Mannkind | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 30.5% | 6.01% |
| Net Income Growth (YoY) | -233.0% | -37.7% |
| EPS Growth (YoY) | -218.2% | -29.2% |
| FCF Growth (YoY) | -163.0% | 2.34% |
| Revenue Growth (3Y CAGR) | 51.8% | 2.25% |
| Revenue Growth (5Y CAGR) | 39.9% | 6.42% |
Balance sheet
| Measure | Mannkind | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $111.13M | $62.42M |
| Net Cash (Debt) | $111.13M | $15.68M |
| Net Cash Per Share | $0.35 | $0.66 |
| Equity (Book Value) | -$67.20M | $48.79M |
| Book Value Per Share | -$0.21 | $1.36 |
| Tangible Book Value | -$139.77M | $23.06M |
| Working Capital | $102.81M | $75.77M |
Financial position
| Measure | Mannkind | Industry median |
|---|---|---|
| Current Ratio | 1.72 | 3.30 |
| Quick Ratio | 1.08 | 2.39 |
| Interest Coverage | 0.33 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Mannkind | Industry median |
|---|---|---|
| Operating Cash Flow | -$8.05M | -$12.35M |
| Capital Expenditures | -$10.08M | -$1.06M |
| Free Cash Flow | -$18.14M | -$20.28M |
| FCF Per Share | -$0.06 | -$0.42 |
Efficiency
| Measure | Mannkind | Industry median |
|---|---|---|
| Asset Turnover | 0.69 | 0.38 |
| Inventory Turnover | 1.11 | 2.67 |
| Revenue Per Employee | $1.63M | $398.96K |
| Profits Per Employee | -$180.97K | -$703.34K |
| Employee Count | 241 | 74 |
Dividends and yields
| Measure | Mannkind | Industry median |
|---|---|---|
| Earnings Yield | -4.39% | -22.7% |
| FCF Yield | -1.83% | -9.07% |
Shares
| Measure | Mannkind | Industry median |
|---|---|---|
| Shares Outstanding | 321,541,000 | 58,179,650 |
| Shares Change (YoY) | 3.09% | 11.1% |
| Shares Change (QoQ) | 0.33% | 0.54% |
| Float | 313,405,000 | 49,173,100 |
| Shares Held by Insiders | 2.53% | 11.6% |
| Shares Held by Institutions | 56.7% | 59.4% |
Taxes
| Measure | Mannkind | Industry median |
|---|---|---|
| Income Tax | -$5.04M | $91.50K |
Scores
| Measure | Mannkind | Industry median |
|---|---|---|
| Altman Z-Score | -4.69 | -0.24 |
| Piotroski F-Score | 5 | 4 |
| Beneish M-Score | 0.77 | -2.62 |
Calculated by StockData from Mannkind's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.